Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SNX | PHM |
|---|---|---|
| Price | $273.97 | $115.55 |
| Change today | ▲ 6.67% | ▼ 0.44% |
| Market cap | $21.66B | $21.66B |
| Return, 3 months | +5.0% | -12.7% |
| Return, year to date | +83.7% | -0.8% |
| Return, 1 year | +68.4% | -13.3% |
| P/E (TTM) | 16.7 | 11.8 |
| P/B | 2.3 | 1.7 |
| P/E percentile vs own 5y | 40th | 92nd |
| Dividend yield | 0.69% | 0.87% |
| Revenue growth (YoY, latest qtr) | +37.7% | -9.6% |
| Net profit growth (YoY) | +83.5% | -22.4% |
| Gross margin | 6.9% | 25.2% |
| Operating margin | 2.7% | 15.6% |
| Net margin | 1.7% | 11.6% |
| Return on equity | 14.9% | 14.9% |
| Analyst target vs. price | +24.9% | +26.5% |
| Analyst buy share | 86% | 64% |
| RSI (14) | 46 | 39 |
| 30-day volatility | 45.8% | 28.0% |
| Max drawdown, 1 year | -18.8% | -22.6% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
